YaoGeJu

Company directoryChina company filings

Jiangsu Shenhua Pharmaceutical Co., Ltd.

As of 20 November 2026, for the company name Jiangsu Shenhua Pharmaceutical Co., Ltd. as recorded, 7 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 25 records, across 23 drug names; since 23 August 2026, the records list Marketing application approved: 1 application, No longer listed under review: 1 application (NMPA data as of 19 November 2026); the chemical-drug catalogue lists 1 active record with this name as holder; 9 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/20
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.

Drug filings

25 acceptance records as first applicant, grouped into 23 source drug names. Source data as of 2026/11/20.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Sacubitril Valsartan Sodium Tablets 2 records · Latest accepted 2026/08/04

Supplement · 1Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601491Supplement2026/08/04Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
CYHS2500144Generic2025/01/09Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Baricitinib Tablets 1 records · Latest accepted 2026/07/24

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601782Generic2026/07/24Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2026/07/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601620Generic2026/07/07Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Bromhexine Hydrochloride Oral Solution 1 records · Latest accepted 2026/06/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601379Generic2026/06/11Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Minoxidil Liniment 2 records · Latest accepted 2026/02/11

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600321Supplement2026/02/11Jiangsu Shenhua Pharmaceutical Co., Ltd.; Shanghai Li Xiang Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2600320Supplement2026/02/11Jiangsu Shenhua Pharmaceutical Co., Ltd.; Shanghai Li Xiang Pharmaceutical Co., Ltd. romanizedCDE ↗
MOVICOL Ready To Take Sachet, Powder For Oral Solution 1 records · Latest accepted 2026/02/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600417Generic2026/02/10Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
人工牛黄甲硝唑胶囊 · No verified English name 1 records · Latest accepted 2025/12/17

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2502537Supplement2025/12/17Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Lactulose Oral Solution 1 records · Latest accepted 2025/12/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504208Generic2025/12/06Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Dapagliflozin Tablets 1 records · Latest accepted 2025/10/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503762Generic2025/10/22Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Vonoprazan Fumarate Tablets 1 records · Latest accepted 2025/09/03

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503240Generic2025/09/03Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Glucosamine Sulfate Capsules 1 records · Latest accepted 2025/05/20

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501034Supplement2025/05/20Jiangsu Shenhua Pharmaceutical Co., Ltd.; Huayi Pharmaceuticals (Anhui) Co., Ltd.CDE ↗
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution 1 records · Latest accepted 2025/01/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500307Generic2025/01/15Jiangsu Shenhua Pharmaceutical Co., Ltd.; Anhui Yong Sheng Tang Pharma Co., Ltd. romanizedCDE ↗
天麻蜜环菌片 · No verified English name 1 records · Latest accepted 2024/10/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401948Supplement2024/10/12Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
宁心宝胶囊 · No verified English name 1 records · Latest accepted 2024/10/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401947Supplement2024/10/12Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
灵芝胶囊 · No verified English name 1 records · Latest accepted 2024/10/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401945Supplement2024/10/12Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
胃乐舒口服液 · No verified English name 1 records · Latest accepted 2024/10/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401949Supplement2024/10/12Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
脑心舒口服液 · No verified English name 1 records · Latest accepted 2024/10/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401946Supplement2024/10/12Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
猴头菌片 · No verified English name 1 records · Latest accepted 2024/08/30

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401640Supplement2024/08/30Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
复方灵芝颗粒 · No verified English name 1 records · Latest accepted 2024/08/28

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401627Supplement2024/08/28Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
云芝肝泰胶囊 · No verified English name 1 records · Latest accepted 2024/08/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401515Supplement2024/08/15Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
云芝肝泰颗粒 · No verified English name 1 records · Latest accepted 2024/08/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401516Supplement2024/08/15Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
云芝菌胶囊 · No verified English name 1 records · Latest accepted 2024/08/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401517Supplement2024/08/15Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
复方氨酚烷胺胶囊 · No verified English name 1 records · Latest accepted 2024/06/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400835Supplement2024/06/18Jiangsu Shenhua Pharmaceutical Co., Ltd.; Haerbin Shi Long Sheng Bei Yao Bio Gong Cheng Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

2 events from 2026/08/23 to 2026/11/20. CDE data as of 2026/11/20; NMPA data as of 2026/11/19.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Marketing application approved: 1 applicationNo longer listed under review: 1 application

  1. 2026/11/20No longer listed under review

    Sacubitril Valsartan Sodium Tablets

    CYHB2601491

    Fact date: 2026/11/20 · Date added to this site: 2026/11/20

    Accepted: 2026/08/04

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  2. 2026/11/03Marketing application approved

    Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

    CYHS2500307 · 国药准字H20266436

    Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06

    View source · Table row 18 ↗

Under review

7 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Baricitinib Tablets CYHS2601782Generic2026/07/24Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Oseltamivir Phosphate Capsules CYHS2601620Generic2026/07/07Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Bromhexine Hydrochloride Oral Solution CYHS2601379Generic2026/06/11Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
MOVICOL Ready To Take Sachet, Powder For Oral Solution CYHS2600417Generic2026/02/10Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Lactulose Oral Solution CYHS2504208Generic2025/12/06Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Dapagliflozin Tablets CYHS2503762Generic2025/10/22Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗
Vonoprazan Fumarate Tablets CYHS2503240Generic2025/09/03Jiangsu Shenhua Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

1 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerNMPA approval no.ApprovedCatalogue category (source text)View source
Sacubitril Valsartan Sodium TabletsJiangsu Shenhua Pharmaceutical Co., Ltd.Jiangsu Shenhua Pharmaceutical Co., Ltd.国药准字H202651542026/07/14Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

9 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.

NameCompany / applicantRegistration numberStatusSource update dateView source
硫酸羟氯喹 · No verified English nameJiangsu Shenhua Pharmaceutical Co., Ltd.Y20190007389A2025/06/09CDE ↗
阿昔莫司 · No verified English nameJiangsu Shenhua Pharmaceutical Co., Ltd.Y20190006407A2026/04/20CDE ↗
虫草头孢菌粉 · No verified English nameJiangsu Shenhua Pharmaceutical Co., Ltd.Y20190002896A2025/04/25CDE ↗
天麻蜜环菌粉 · No verified English nameJiangsu Shenhua Pharmaceutical Co., Ltd.Y20190002876A2025/06/21CDE ↗
云芝胞内糖肽 · No verified English nameJiangsu Shenhua Pharmaceutical Co., Ltd.Y20190002875A2025/05/20CDE ↗
白葡萄球菌粉 · No verified English nameJiangsu Shenhua Pharmaceutical Co., Ltd.Y20190002874A2025/03/19CDE ↗
虫草被孢菌粉 · No verified English nameJiangsu Shenhua Pharmaceutical Co., Ltd.Y20190002873A2025/05/20CDE ↗
谷氨酰胺 · No verified English nameJiangsu Shenhua Pharmaceutical Co., Ltd.Y20190002868A2025/04/25CDE ↗
猴头菌粉 · No verified English nameJiangsu Shenhua Pharmaceutical Co., Ltd.Y20190002861A2025/04/25CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/20
Chemical-drug catalogue
Last successful update: 2026/11/20
API registrations
Last successful update: 2026/11/20
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.